Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (NASDAQ:TPIV)

4.17
Delayed Data
As of Apr 27
 +0.06 / +1.46%
Today’s Change
3.32
Today|||52-Week Range
9.12
+7.47%
Year-to-Date
No recent news for TapImmune Inc.

Today’s Trading

Previous close4.11
Today’s open4.11
Day’s range4.11 - 4.70
Volume39,187
Average volume (3 months)40,555
Market cap$34.7M
Dividend yield--
Data as of 04/27/2017

Growth & Valuation

Earnings growth (last year)+92.31%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.60

Competitors

 Today’s
change
Today’s
% change
PPHMPPeregrine Pharmaceut...-0.11-0.49%
NVLSNivalis Therapeutics...-0.04-1.77%
SVRASavara Inc----
PRPHProPhase Labs Inc-0.01-0.29%
Data as of 04/27/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$2.5M
Net profit margin--

Profile

Sector
Consumer Services
Industry
Other Consumer Services
Chairman &
Chief Executive Officer
Glynn Wilson
President, Chief Operating Officer &
Director
John N. Bonfiglio
Corporate headquarters
Jacksonville, Florida

Forecasts